- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05003193
The Effect of Walking in Kidney Transplant Patients
6. august 2021 opdateret af: FATMA DEMIR KORKMAZ, Ege University
The Effect of Pedometer Assisted Walking on Physical Activity Level and Metabolic Parameters in Patients With Renal Transplantation
Cardiovascular diseases are among the most common causes of death in kidney transplant patients.
Physical activity is of great importance in preventing cardiovascular diseases after transplantation.
Although regular physical activity is recommended in international guidelines to prevent post-transplant mortality and morbidity in kidney transplant patients, studies have shown that patients do not follow regular physical activity instructions.The aim of our project is to examine the effect of pedometer-assisted physical activity on metabolic parameters after kidney transplantation.
Studieoversigt
Status
Rekruttering
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Patients with kidney transplant surgery will be randomized to the intervention (n: 34) and control groups (n: 34), respectively, according to the transplant surgery date.
Intervention and Control groups will be given the same training on the importance of physical activity during discharge training.
The pedometer will be given to the intervention group to evaluate the activity level, and it will be said that their goal is to take 2000 steps in 20 minutes a day after discharge.
Patients will be asked to carry the pedometer during physical activity, and to write down the number of steps they take in 20 minutes on the form given to them for 90 days.
Patients in the control group will only be advised to do physical activity every day and will be asked to record the minutes of physical activity they do for 90 days.
Metabolic parameters of the patients in the intervention and control groups will be examined at the end of the 4th and 12th months.
These parameters are blood pressure, body mass index, complete blood count (hemoglobin, leukocyte, thrombocyte), blood glucose, sodium, potassium, calcium, liver enzymes, serum creatinine, total and indirect bilirubin, albumin and total cholesterol levels.
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
68
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Fatma DEMIR KORKMAZ, Professor
- Telefonnummer: +902323115506
- E-mail: fatma.demir@ege.edu.tr
Undersøgelse Kontakt Backup
- Navn: Tugba Nur ODEN, PhD Student
- Telefonnummer: +902323905106
- E-mail: tugba.nur.zoturk@ege.edu.tr
Studiesteder
-
-
-
Izmir, Kalkun, 35040
- Rekruttering
- Ege University
-
Kontakt:
- Fatma DEMIR KORKMAZ, Professor
- Telefonnummer: +902323115506
- E-mail: fatma.demir@ege.edu.tr
-
Kontakt:
- Tugba Nur ODEN, PhD Student
- Telefonnummer: +902323905106
- E-mail: tugba.nur.ozturk@ege.edu.tr
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 65 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria: • Over the age of 18 and under the age of 65,
- Kidney transplantation at the center where the study was conducted between the research dates,
- There is no activity restriction recommendation by the physician,
- Patients who agree to participate in the study.
Exclusion Criteria:
- Multiple organ transplantation at the same time,
- Death or graft loss/rejection in the hospital before discharge,
- Patients with physical activity restrictions by the physician,
- Patients who are re-hospitalized within the first 3 months after discharge
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Using a pedometer
The pedometer will be given to the intervention group to evaluate the activity level and to encourage a walk , it will be said that their goal is to take 2000 steps in 20 minutes a day after discharge.
Patients will be asked to carry the pedometer during physical activity, and to write down the number of steps they take in 20 minutes on the form given to them for 90 days.
|
2000 steps per day in 20 minutes for 90 days, guided by a pedometer after a kidney transplantation
|
Ingen indgriben: Not using a pedometer
The control group will not be given a pedometer.Patients in the control group will only be instructed to do physical activity every day and will be asked to record the minutes of physical activity they do for 90 days.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Blood Pressure
Tidsramme: Change from Baseline Blood Pressure at 4 months after discharge
|
mmHg
|
Change from Baseline Blood Pressure at 4 months after discharge
|
Blood Pressure
Tidsramme: Change from Baseline Blood Pressure at 12 months after discharge
|
mmHg
|
Change from Baseline Blood Pressure at 12 months after discharge
|
Body Mass Index (BMI)
Tidsramme: Change from Baseline BMI at 4 months after discharge
|
BMI is weight in kilograms divided by height in meters squared.
Formula: weight (kg) / [height (m)]2
|
Change from Baseline BMI at 4 months after discharge
|
Body Mass Index (BMI)
Tidsramme: Change from Baseline BMI at 12 months after discharge
|
BMI is weight in kilograms divided by height in meters squared.
Formula: weight (kg) / [height (m)]2
|
Change from Baseline BMI at 12 months after discharge
|
Hemoglobin
Tidsramme: Change from Baseline Hemoglobin at 4 months after discharge
|
g/dL
|
Change from Baseline Hemoglobin at 4 months after discharge
|
Hemoglobin
Tidsramme: Change from Baseline Hemoglobin at 12 months after discharge
|
g/dL
|
Change from Baseline Hemoglobin at 12 months after discharge
|
Leukocyte
Tidsramme: Change from Baseline Leukocyte at 4 months after discharge
|
10^3/µL
|
Change from Baseline Leukocyte at 4 months after discharge
|
Leukocyte
Tidsramme: Change from Baseline Leukocyte at 12 months after discharge
|
10^3/µL
|
Change from Baseline Leukocyte at 12 months after discharge
|
Thrombocyte
Tidsramme: Change from Baseline Thrombocyte at 4 months after discharge
|
10^3/µL
|
Change from Baseline Thrombocyte at 4 months after discharge
|
Thrombocyte
Tidsramme: Change from Baseline Thrombocyte at 12 months after discharge
|
10^3/µL
|
Change from Baseline Thrombocyte at 12 months after discharge
|
Blood Glucose
Tidsramme: Change from Baseline Blood Glucose at 4 months after discharge
|
mg/dL
|
Change from Baseline Blood Glucose at 4 months after discharge
|
Blood Glucose
Tidsramme: Change from Baseline Blood Glucose at 12 months after discharge
|
mg/dL
|
Change from Baseline Blood Glucose at 12 months after discharge
|
Sodium
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
mEq/L
|
Change from Baseline Sodium at 4 months after discharge
|
Sodium
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
mEq/L
|
Change from Baseline Sodium at 12 months after discharge
|
Potassium
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
mEq/L
|
Change from Baseline Sodium at 4 months after discharge
|
Potassium
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
mEq/L
|
Change from Baseline Sodium at 12 months after discharge
|
Calcium
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
mEq/L
|
Change from Baseline Sodium at 4 months after discharge
|
Calcium
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
mEq/L
|
Change from Baseline Sodium at 12 months after discharge
|
Serum Creatinine
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 4 months after discharge
|
Serum Creatinine
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 12 months after discharge
|
Total Bilirubin
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 4 months after discharge
|
Total Bilirubin
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 12 months after discharge
|
Indirect Bilirubin
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 4 months after discharge
|
Indirect Bilirubin
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 12 months after discharge
|
High-density lipoprotein (HDL) cholesterol
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 4 months after discharge
|
High-density lipoprotein (HDL) cholesterol
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 12 months after discharge
|
Low-density lipoprotein (LDL) cholesterol
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 4 months after discharge
|
Low-density lipoprotein (LDL) cholesterol
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 12 months after discharge
|
Aspartate Aminotransferase
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
U/L
|
Change from Baseline Sodium at 4 months after discharge
|
Aspartate Aminotransferase
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
U/L
|
Change from Baseline Sodium at 12 months after discharge
|
Alanine aminotransferase
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
U/L
|
Change from Baseline Sodium at 4 months after discharge
|
Alanine aminotransferase
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
U/L
|
Change from Baseline Sodium at 12 months after discharge
|
Alkaline Phosphatase
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
U/L
|
Change from Baseline Sodium at 4 months after discharge
|
Alkaline Phosphatase
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
U/L
|
Change from Baseline Sodium at 12 months after discharge
|
Triglyceride
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 4 months after discharge
|
Triglyceride
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 12 months after discharge
|
Total Cholesterol
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 4 months after discharge
|
Total Cholesterol
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 12 months after discharge
|
Albumin
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
g/dL
|
Change from Baseline Sodium at 4 months after discharge
|
Albumin
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
g/dL
|
Change from Baseline Sodium at 12 months after discharge
|
glucose in urine
Tidsramme: Change from Baseline Sodium at 4 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 4 months after discharge
|
glucose in urine
Tidsramme: Change from Baseline Sodium at 12 months after discharge
|
mg/dL
|
Change from Baseline Sodium at 12 months after discharge
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Fatma DEMIR KORKMAZ, Professor, Ege University Faculty of Nursing 35000, Izmir, Turkey
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, Macera CA, Castaneda-Sceppa C; American College of Sports Medicine; American Heart Association. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation. 2007 Aug 28;116(9):1094-105. doi: 10.1161/CIRCULATIONAHA.107.185650. Epub 2007 Aug 1.
- Zelle DM, Kok T, Dontje ML, Danchell EI, Navis G, van Son WJ, Bakker SJ, Corpeleijn E. The role of diet and physical activity in post-transplant weight gain after renal transplantation. Clin Transplant. 2013 Jul-Aug;27(4):E484-90. doi: 10.1111/ctr.12149. Epub 2013 Jun 13.
- Zelle DM, Corpeleijn E, Klaassen G, Schutte E, Navis G, Bakker SJ. Fear of Movement and Low Self-Efficacy Are Important Barriers in Physical Activity after Renal Transplantation. PLoS One. 2016 Feb 4;11(2):e0147609. doi: 10.1371/journal.pone.0147609. eCollection 2016.
- Lorenz EC, Amer H, Dean PG, Stegall MD, Cosio FG, Cheville AL. Adherence to a pedometer-based physical activity intervention following kidney transplant and impact on metabolic parameters. Clin Transplant. 2015 Jun;29(6):560-8. doi: 10.1111/ctr.12553. Epub 2015 May 26.
- Gustaw T, Schoo E, Barbalinardo C, Rodrigues N, Zameni Y, Motta VN, Mathur S, Janaudis-Ferreira T. Physical activity in solid organ transplant recipients: Participation, predictors, barriers, and facilitators. Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12929. Epub 2017 Mar 14.
- Aakhus S, Dahl K, Widerøe TE. Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up. Clin Transplant. 2004 Oct;18(5):596-604.
- Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation. 2006 Sep 15;82(5):603-11. doi: 10.1097/01.tp.0000235527.81917.fe.
- Berben L, Engberg SJ, Rossmeissl A, Gordon EJ, Kugler C, Schmidt-Trucksäss A, Klem ML, Sereika SM, De Simone P, Dobbels F, De Geest SM; B-SERIOUS consortium. Correlates and Outcomes of Low Physical Activity Posttransplant: A Systematic Review and Meta-Analysis. Transplantation. 2019 Apr;103(4):679-688. doi: 10.1097/TP.0000000000002543.
- Dontje ML, de Greef MH, Krijnen WP, Corpeleijn E, Kok T, Bakker SJ, Stolk RP, van der Schans CP. Longitudinal measurement of physical activity following kidney transplantation. Clin Transplant. 2014 Apr;28(4):394-402. doi: 10.1111/ctr.12325. Epub 2014 Mar 17.
- Gordon EJ, Prohaska TR, Gallant MP, Sehgal AR, Strogatz D, Yucel R, Conti D, Siminoff LA. Longitudinal analysis of physical activity, fluid intake, and graft function among kidney transplant recipients. Transpl Int. 2009 Oct;22(10):990-8. doi: 10.1111/j.1432-2277.2009.00917.x. Epub 2009 Jul 10.
- Hawkins MS, Sevick MA, Richardson CR, Fried LF, Arena VC, Kriska AM. Association between physical activity and kidney function: National Health and Nutrition Examination Survey. Med Sci Sports Exerc. 2011 Aug;43(8):1457-64. doi: 10.1249/MSS.0b013e31820c0130.
- Svensson M, Jardine A, Fellström B, Holdaas H. Prevention of cardiovascular disease after renal transplantation. Curr Opin Organ Transplant. 2012 Aug;17(4):393-400. doi: 10.1097/MOT.0b013e3283560a3b. Review.
- Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009 Nov;9 Suppl 3:S1-155. doi: 10.1111/j.1600-6143.2009.02834.x.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
19. november 2020
Primær færdiggørelse (Forventet)
1. november 2022
Studieafslutning (Forventet)
1. november 2022
Datoer for studieregistrering
Først indsendt
30. marts 2021
Først indsendt, der opfyldte QC-kriterier
6. august 2021
Først opslået (Faktiske)
12. august 2021
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
12. august 2021
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
6. august 2021
Sidst verificeret
1. august 2021
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- fatma.demir1
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Hjertesygdom
-
Impulse DynamicsRekrutteringEvaluer sikkerheden og anvendeligheden af ODOCOR II Intra-cardiac LeadSpanien, Tyskland, Italien
-
Abbott Medical DevicesAfsluttetPatienten opfylder ACC/AHA/ESC-retningslinjerne for implanterbar cardioverter-defibrillator (ICD) eller cardiac resynchronization therapy (CRT-D)-enhedDet Forenede Kongerige, Tyskland
-
Reham SameehAssiut UniversityUkendtCardiac Magnetic Resonance Imaging i ikke-iskæmisk kardiomyopati
-
Milton S. Hershey Medical CenterRekrutteringVenstre ventrikulær dysfunktion | Spinalbedøvelsesmidler, der forårsager uønskede virkninger ved terapeutisk brug | Global Cardiac Wall Motion DysfunktionForenede Stater
-
University of AarhusAfsluttetHjertestop | Hypotermi | Post Cardiac Arrest SyndromeDanmark
-
Russian Federation of Anesthesiologists and ReanimatologistsRekrutteringPost Cardiac Arrest SyndromeDen Russiske Føderation
-
University of AarhusUkendtHjertestop uden for hospitalet | Post Cardiac Arrest SyndromeDanmark
-
Ospedale San Giovanni BellinzonaSwiss Heart FoundationAfsluttetAkut myokardieinfarkt | Takotsubo kardiomyopati | Cardiac X syndromSchweiz
-
University Medical Center GroningenUkendtAkutmedicinske tjenester | Hjertestop uden for hospitalet | Post Cardiac Arrest Syndrome
-
University of FlorenceSandro Gelsomino; Edvin Prifti; Francesco Cabrucci; Marco Bugetti; Orlando Parise og andre samarbejdspartnereRekrutteringKardiogent stød | Ekstrakorporal membraniltningskomplikation | Post-hjertekirurgi | Ekstrakorporal livsstøtte | Post Cardiac Arrest SyndromeItalien